Literature DB >> 25757546

Production of retroviral constructs for effective transfer and expression of T-cell receptor genes using Golden Gate cloning.

Lori V Coren1, Sumiti Jain1, Matthew T Trivett1, Claes Ohlen1, David E Ott1.   

Abstract

Here we present an improved strategy for producing T-cell receptor (TCR)-expressing retroviral vectors using a Golden Gate cloning strategy. This method takes advantage of the modular nature of TCR genes by directly amplifying TCR α and β variable regions from RNA or cDNA, then cloning and fusing them with their respective constant region genes resident in a retroviral TCR expression vector. Our one-step approach greatly streamlines the TCR vector production process in comparison to the traditional three-step procedure that typically involves cloning whole TCR genes, producing a TCR expression cassette, and constructing a retroviral construct. To date, we have generated TCR vectors that transferred seven functional human/rhesus macaque TCRs into primary T cells. The approach also holds promise for the assembly of other genes with defined variable regions, such as immunoglobulins.

Entities:  

Keywords:  Golden Gate cloning; T-cell receptor; gene engineering; retroviral vector

Mesh:

Substances:

Year:  2015        PMID: 25757546      PMCID: PMC4827251          DOI: 10.2144/000114265

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  13 in total

1.  Efficient gene transfer to hematopoietic repopulating cells using concentrated RD114-pseudotype vectors produced by human packaging cells.

Authors:  Tobias Neff; Laura J Peterson; Julia C Morris; Jesse Thompson; Xiaobing Zhang; Peter A Horn; Bobbie M Thomasson; Hans-Peter Kiem
Journal:  Mol Ther       Date:  2004-02       Impact factor: 11.454

2.  Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines.

Authors:  Yangbing Zhao; Zhili Zheng; Paul F Robbins; Hung T Khong; Steven A Rosenberg; Richard A Morgan
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

3.  Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line.

Authors:  A Weiss; J D Stobo
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

4.  Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer.

Authors:  P S Ohashi; T W Mak; P Van den Elsen; Y Yanagi; Y Yoshikai; A F Calman; C Terhorst; J D Stobo; A Weiss
Journal:  Nature       Date:  1985 Aug 15-21       Impact factor: 49.962

5.  Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions.

Authors:  Marybeth S Hughes; Yik Y L Yu; Mark E Dudley; Zhili Zheng; Paul F Robbins; Yong Li; John Wunderlich; Robert G Hawley; Morvarid Moayeri; Steven A Rosenberg; Richard A Morgan
Journal:  Hum Gene Ther       Date:  2005-04       Impact factor: 5.695

Review 6.  T cell receptor gene therapy for cancer.

Authors:  Thomas M Schmitt; Gunnar B Ragnarsson; Philip D Greenberg
Journal:  Hum Gene Ther       Date:  2009-11       Impact factor: 5.695

7.  Nef-mediated MHC class I down-regulation unmasks clonal differences in virus suppression by SIV-specific CD8(+) T cells independent of IFN-gamma and CD107a responses.

Authors:  Jacob T Minang; Matthew T Trivett; Lori V Coren; Eugene V Barsov; Michael Piatak; David E Ott; Claes Ohlen
Journal:  Virology       Date:  2009-06-24       Impact factor: 3.616

8.  Quick and clean cloning: a ligation-independent cloning strategy for selective cloning of specific PCR products from non-specific mixes.

Authors:  Frank Thieme; Carola Engler; Romy Kandzia; Sylvestre Marillonnet
Journal:  PLoS One       Date:  2011-06-02       Impact factor: 3.240

9.  Golden gate shuffling: a one-pot DNA shuffling method based on type IIs restriction enzymes.

Authors:  Carola Engler; Ramona Gruetzner; Romy Kandzia; Sylvestre Marillonnet
Journal:  PLoS One       Date:  2009-05-14       Impact factor: 3.240

10.  A one pot, one step, precision cloning method with high throughput capability.

Authors:  Carola Engler; Romy Kandzia; Sylvestre Marillonnet
Journal:  PLoS One       Date:  2008-11-05       Impact factor: 3.240

View more
  7 in total

1.  A novel SIV gag-specific CD4(+)T-cell clone suppresses SIVmac239 replication in CD4(+)T cells revealing the interplay between antiviral effector cells and their infected targets.

Authors:  Victor I Ayala; Matthew T Trivett; Lori V Coren; Sumiti Jain; Patrick S Bohn; Roger W Wiseman; David H O'Connor; Claes Ohlen; David E Ott
Journal:  Virology       Date:  2016-03-25       Impact factor: 3.616

2.  CXCR5-Dependent Entry of CD8 T Cells into Rhesus Macaque B-Cell Follicles Achieved through T-Cell Engineering.

Authors:  Victor I Ayala; Claire Deleage; Matthew T Trivett; Sumiti Jain; Lori V Coren; Matthew W Breed; Joshua A Kramer; James A Thomas; Jacob D Estes; Jeffrey D Lifson; David E Ott
Journal:  J Virol       Date:  2017-05-12       Impact factor: 6.549

3.  A novel one-step approach for the construction of yeast surface display Fab antibody libraries.

Authors:  Simon Rosowski; Stefan Becker; Lars Toleikis; Bernhard Valldorf; Julius Grzeschik; Deniz Demir; Iris Willenbücher; Ramona Gaa; Harald Kolmar; Stefan Zielonka; Simon Krah
Journal:  Microb Cell Fact       Date:  2018-01-09       Impact factor: 5.328

4.  T-cell responses to KSHV infection: a systematic approach.

Authors:  Romin Roshan; Nazzarena Labo; Matthew Trivett; Wendell Miley; Vickie Marshall; Lori Coren; Elena M Cornejo Castro; Hannah Perez; Benjamin Holdridge; Eliza Davis; Rodrigo Matus-Nicodemos; Victor I Ayala; Raymond Sowder; Kathleen M Wyvill; Karen Aleman; Christine Fennessey; Jeffrey Lifson; Mark N Polizzotto; Daniel Douek; Brandon Keele; Thomas S Uldrick; Robert Yarchoan; Claes Ohlen; David Ott; Denise Whitby
Journal:  Oncotarget       Date:  2017-11-25

5.  The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function.

Authors:  Mathias Wenes; Alison Jaccard; Tania Wyss; Noelia Maldonado-Pérez; Shao Thing Teoh; Anouk Lepez; Fabrice Renaud; Fabien Franco; Patrice Waridel; Céline Yacoub Maroun; Benjamin Tschumi; Nina Dumauthioz; Lianjun Zhang; Alena Donda; Francisco Martín; Denis Migliorini; Sophia Y Lunt; Ping-Chih Ho; Pedro Romero
Journal:  Cell Metab       Date:  2022-04-21       Impact factor: 31.373

6.  CART cells are prone to Fas- and DR5-mediated cell death.

Authors:  Benjamin O Tschumi; Nina Dumauthioz; Bastien Marti; Lianjun Zhang; Evripidis Lanitis; Melita Irving; Pascal Schneider; Jean-Pierre Mach; Pedro Romero; Alena Donda
Journal:  J Immunother Cancer       Date:  2018-07-13       Impact factor: 13.751

7.  Elongation factor-2 kinase is a critical determinant of the fate and antitumor immunity of CD8+ T cells.

Authors:  Jugal Kishore Das; Yijie Ren; Anil Kumar; Hao-Yun Peng; Liqing Wang; Xiaofang Xiong; Robert C Alaniz; Paul de Figueiredo; Xingcong Ren; Xiaoqi Liu; Alexey G Ryazonov; Jin-Ming Yang; Jianxun Song
Journal:  Sci Adv       Date:  2022-02-02       Impact factor: 14.136

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.